Validation of the Use of Middlebrook 7H10 Agar, BACTEC MGIT 960, and BACTEC 460 12B Media for Testing the Susceptibility of Mycobacterium tuberculosis to Levofloxacin
Open Access
- 1 November 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (11) , 5225-5228
- https://doi.org/10.1128/jcm.42.11.5225-5228.2004
Abstract
Levofloxacin, the active l -isomer of the quinolone ofloxacin, is now widely accepted for treatment of multidrug-resistant tuberculosis. Because the drug is now widely used, we sought to establish susceptibility test conditions for Mycobacterium tuberculosis against levofloxacin by the traditional reference method, agar proportion (AP), the commonly used BACTEC 460 radiometric system, and the newer BACTEC MGIT 960 method. To determine the stability of levofloxacin in the two newer test systems (BACTEC 460 and BACTEC MGIT 960), media containing subinhibitory levels of levofloxacin were prepared and stored at 4 and 37°C for 14 days. The stored media were inoculated with H37Rv, and the drug activity was compared to freshly prepared media. Results show that levofloxacin is stable over the course of testing. Next, optimum levofloxacin test concentrations were determined for AP, BACTEC 460, and BACTEC MGIT 960 methods. MICs were determined for 32 pan-susceptible isolates of M. tuberculosis obtained from presumably untreated patients and 14 quinolone-resistant isolates. The levofloxacin-resistant strains either were isolated from patients who remained culture-positive despite treatment with a quinolone agent (six strains) or contained known mutations in gyrA (eight strains). Levofloxacin MICs resulted in a bimodal pattern with values for resistant strains consistently higher than those for pan-susceptible strains. Results show that levofloxacin concentrations of 2 μg/ml (BACTEC 460 and BACTEC MGIT 960) and 1 μg/ml (AP) inhibited the growth of all pan-susceptible strains while permitting the growth of all levofloxacin-resistant strains. Confirmatory tests with a subset of pan-susceptible and levofloxacin-resistant isolates validated the selected test concentrations.Keywords
This publication has 15 references indexed in Scilit:
- Comparative Roles of Levofloxacin and Ofloxacin in the Treatment of Multidrug-Resistant TuberculosisChest, 2003
- The global tuberculosis situation: Progress and problems in the 20th century, prospects for the 21st centuryInfectious Disease Clinics of North America, 2002
- Evaluation of Automated BACTEC MGIT 960 System for Testing Susceptibility of Mycobacterium tuberculosis to Four Major Antituberculous Drugs: Comparison with the Radiometric BACTEC 460TB Method and the Agar Plate Method of ProportionJournal of Clinical Microbiology, 2002
- In vitro activity of four fluoroquinolones against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2001
- In Vitro Activities of Six Fluoroquinolones against 250 Clinical Isolates of Mycobacterium tuberculosis Susceptible or Resistant to First-Line Antituberculosis DrugsAntimicrobial Agents and Chemotherapy, 2000
- Susceptibility to levofloxacin of Mycobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistanceAIDS, 1997
- Fluoroquinolone Resistance Associated with Specific Gyrase Mutations in Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosisThe Journal of Infectious Diseases, 1996
- In vitro and in vivo activities of levofloxacin against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1995
- Inhibitory and bactericidal activities of levofloxacin against Mycobacterium tuberculosis in vitro and in human macrophagesAntimicrobial Agents and Chemotherapy, 1994
- Stability of antimycobacterial drugs in susceptibility testingAntimicrobial Agents and Chemotherapy, 1992